Table 2.
Influence of AR expression on BCa patient survival.
| Type | Comparison | Increased survival | P-value | HR | Reference |
|---|---|---|---|---|---|
| ESR1+ | AR low vs high | AR-high | 0.002 | 0.22 | Peters et al. 2009 |
| ESR1− | AR low vs high | no difference | 0.32 | NA | Peters et al. 2009 |
| TCGA-BRCA | AR low vs high | AR-high | 1.10E-16 | 0.52 | Ponnusamy et al. 2019 |
AR, androgen receptor; ESR1, estrogen receptor α; HR, hazard ratio; NA, not applicable or indicated; PGR, progesterone receptor; TCGA-BRCA, The Cancer Genome Atlas Breast Invasive Carcinoma.
This work is licensed under a